Top Markets
Coin of the day
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPT
Ранг среди акций #12019
Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the... Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.
Цена акции
$19.00
Последняя синхронизация: 2023-11-14
Рыночная капитализация
$629.64M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Intercept Pharmaceuticals, Inc. (ICPT)

Категория

История цены акций Intercept Pharmaceuticals, Inc. (ICPT)
Наивысшая цена закрытия: $18.99 2023-11-01

Наименьшая цена закрытия: $19.35 2012-10-01
История цены акций Intercept Pharmaceuticals, Inc. с 2012 по 2026
Годовая динамика цены акций
Год Результативность
2023 39.35%
2022 -16.08%
2021 -46.76%
2020 -74.21%
2019 16.21%
2018 65.23%
2017 -41.82%
2016 -32.31%
2015 8.19%
2014 138.13%
2013 92.89%
2012 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.36 -12.82%
AU
$138.18 473.58%
US
$759.27 7.20%
CH